Search This Blog

Tuesday, February 11, 2025

Wedbush Raises Price Target on Travere Therapeutics to $30 From $26

 Maintains Outperform Rating

https://www.marketscreener.com/quote/stock/TRAVERE-THERAPEUTICS-INC-15458731/news/Wedbush-Raises-Price-Target-on-Travere-Therapeutics-to-30-From-26-Maintains-Outperform-Rating-49023219/

Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)